Stay updated on RTX-240 Combo with Pembrolizumab in Clinical Trial
Sign up to get notified when there's something new on the RTX-240 Combo with Pembrolizumab in Clinical Trial page.

Latest updates to the RTX-240 Combo with Pembrolizumab in Clinical Trial page
- Check4 days agoChange DetectedA new study record revision v3.6.3 was added to the history and the older revision v3.6.0 was removed, reflecting an update to the record's documentation.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedRecruitment for RTX-240 is no longer open, indicating a closed enrollment status in the study history. The record now shows Revision: v3.6.0 (replacing the prior v3.5.5).SummaryDifference0.5%

- Check26 days agoChange DetectedA new release note 'Revision: v3.5.5' was added to the page history. The previous release note 'Revision: v3.5.4' was removed.SummaryDifference0.1%

- Check47 days agoChange DetectedA new revision entry v3.5.4 is added to the Record History, replacing the previous v3.5.3 entry.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page’s footer revision label has been updated from **v3.5.0** to **v3.5.3**, reflecting a site/version change rather than any modification to the underlying study record.SummaryDifference0.1%

- Check105 days agoChange DetectedAdded Revision: v3.5.0 to the history. Removed Revision: v3.4.3 from the history.SummaryDifference0.1%

Stay in the know with updates to RTX-240 Combo with Pembrolizumab in Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RTX-240 Combo with Pembrolizumab in Clinical Trial page.